Orient Bio Inc
KRX:002630

Watchlist Manager
Orient Bio Inc Logo
Orient Bio Inc
KRX:002630
Watchlist
Price: 635 KRW -1.4% Market Closed
Market Cap: 75.3B KRW

Net Margin
Orient Bio Inc

-28.8%
Current
5%
Average
1%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-28.8%
=
Net Income
-8.5B
/
Revenue
29.7B

Net Margin Across Competitors

No Stocks Found

Orient Bio Inc
Glance View

ORIENTBIO, Inc. engages in the research and development of biotechnology. The company is headquartered in Seongnam, Gyeonggi-Do and currently employs 104 full-time employees. The firm produces and supplies laboratory animals, including mice, rats, guinea pigs, hamsters, specific pathogen free (SPF) rabbits, beagles and others. The company also provides contract research organization (CRO) services, including CRO safety assessment and CRO new drug development services; medical and library equipment, such as barrier systems, and support services such as rodent surgery services, laboratory diagnostics services, transgenic services, genetic testing services and other services. In addition, along with its subsidiaries, the Company provides feeds, reagents, disinfectants, automobile components, power supply equipment, and other machines.

Intrinsic Value
362.58 KRW
Overvaluation 43%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-28.8%
=
Net Income
-8.5B
/
Revenue
29.7B
What is the Net Margin of Orient Bio Inc?

Based on Orient Bio Inc's most recent financial statements, the company has Net Margin of -28.8%.

Back to Top